News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
707,861 Results
Type
Article (40411)
Company Profile (274)
Press Release (667175)
Multimedia
Podcasts (64)
Webinars (14)
Section
Business (205211)
Career Advice (2024)
Deals (35569)
Drug Delivery (97)
Drug Development (81340)
Employer Resources (172)
FDA (16279)
Job Trends (14943)
News (346789)
Policy (32717)
Tag
Academia (2574)
Accelerated approval (10)
Adcomms (22)
Allergies (95)
Alliances (49915)
ALS (108)
Alzheimer's disease (1452)
Antibody-drug conjugate (ADC) (154)
Approvals (16278)
Artificial intelligence (313)
Autoimmune disease (29)
Automation (19)
Bankruptcy (364)
Best Places to Work (11658)
BIOSECURE Act (20)
Biosimilars (123)
Biotechnology (190)
Bladder cancer (94)
Brain cancer (34)
Breast cancer (367)
Cancer (2881)
Cardiovascular disease (213)
Career advice (1693)
Career pathing (30)
CAR-T (188)
CDC (30)
Cell therapy (507)
Cervical cancer (22)
Clinical research (66993)
Collaboration (1026)
Company closure (3)
Compensation (686)
Complete response letters (23)
COVID-19 (2640)
CRISPR (57)
C-suite (332)
Cystic fibrosis (113)
Data (3004)
Decentralized trials (2)
Denatured (23)
Depression (63)
Diabetes (347)
Diagnostics (6445)
Digital health (23)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (139)
Drug pricing (123)
Drug shortages (28)
Duchenne muscular dystrophy (126)
Earnings (87593)
Editorial (40)
Employer branding (21)
Employer resources (148)
Events (114266)
Executive appointments (853)
FDA (17941)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (941)
Gene editing (131)
Generative AI (22)
Gene therapy (375)
GLP-1 (787)
Government (4516)
Grass and pollen (4)
Guidances (181)
Healthcare (18859)
HIV (40)
Huntington's disease (31)
IgA nephropathy (39)
Immunology and inflammation (152)
Immuno-oncology (9)
Indications (39)
Infectious disease (2814)
Inflammatory bowel disease (153)
Inflation Reduction Act (12)
Influenza (63)
Intellectual property (120)
Interviews (312)
IPO (16624)
IRA (46)
Job creations (3672)
Job search strategy (1436)
Kidney cancer (13)
Labor market (52)
Layoffs (499)
Leadership (18)
Legal (7965)
Liver cancer (79)
Longevity (11)
Lung cancer (400)
Lymphoma (209)
Machine learning (11)
Management (58)
Manufacturing (389)
MASH (90)
Medical device (13476)
Medtech (13481)
Mergers & acquisitions (19665)
Metabolic disorders (851)
Multiple sclerosis (97)
NASH (16)
Neurodegenerative disease (115)
Neuropsychiatric disorders (33)
Neuroscience (2133)
NextGen: Class of 2025 (6553)
Non-profit (4499)
Now hiring (47)
Obesity (428)
Opinion (221)
Ovarian cancer (101)
Pain (107)
Pancreatic cancer (122)
Parkinson's disease (186)
Partnered (22)
Patents (300)
Patient recruitment (166)
Peanut (50)
People (58026)
Pharmaceutical (67)
Pharmacy benefit managers (21)
Phase I (20888)
Phase II (29514)
Phase III (21957)
Pipeline (1640)
Policy (203)
Postmarket research (2564)
Preclinical (8905)
Press Release (64)
Prostate cancer (140)
Psychedelics (37)
Radiopharmaceuticals (253)
Rare diseases (461)
Real estate (5963)
Recruiting (66)
Regulatory (22707)
Reports (50)
Research institute (2333)
Resumes & cover letters (351)
Rett syndrome (9)
RNA editing (9)
RSV (49)
Schizophrenia (86)
Series A (162)
Series B (109)
Service/supplier (13)
Sickle cell disease (60)
Special edition (18)
Spinal muscular atrophy (148)
Sponsored (32)
Startups (3643)
State (2)
Stomach cancer (14)
Supply chain (76)
Tariffs (57)
The Weekly (39)
Vaccines (783)
Venture capital (56)
Weight loss (258)
Women's health (47)
Worklife (16)
Date
Today (94)
Last 7 days (366)
Last 30 days (1843)
Last 365 days (31292)
2025 (16898)
2024 (35332)
2023 (40179)
2022 (51287)
2021 (55834)
2020 (54153)
2019 (46641)
2018 (35123)
2017 (32222)
2016 (31629)
2015 (37707)
2014 (31455)
2013 (26499)
2012 (28770)
2011 (29427)
2010 (27525)
Location
Africa (723)
Alabama (61)
Alaska (7)
Arizona (244)
Arkansas (13)
Asia (38429)
Australia (6280)
California (7475)
Canada (2361)
China (673)
Colorado (322)
Connecticut (318)
Delaware (192)
Europe (82632)
Florida (1119)
Georgia (248)
Hawaii (1)
Idaho (60)
Illinois (641)
India (28)
Indiana (362)
Iowa (16)
Japan (229)
Kansas (110)
Kentucky (29)
Louisiana (14)
Maine (64)
Maryland (1024)
Massachusetts (5550)
Michigan (246)
Minnesota (452)
Mississippi (3)
Missouri (90)
Montana (28)
Nebraska (25)
Nevada (81)
New Hampshire (67)
New Jersey (2082)
New Mexico (28)
New York (2086)
North Carolina (1081)
North Dakota (8)
Northern California (3289)
Ohio (238)
Oklahoma (16)
Oregon (35)
Pennsylvania (1614)
Puerto Rico (17)
Rhode Island (36)
South America (1101)
South Carolina (34)
South Dakota (1)
Southern California (2798)
Tennessee (126)
Texas (1133)
United States (27668)
Utah (220)
Virginia (187)
Washington D.C. (73)
Washington State (636)
West Virginia (4)
Wisconsin (66)
707,861 Results for "mbx biosciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
MBX Biosciences to Participate in June Investor Conferences
May 20, 2025
·
1 min read
Press Releases
MBX Biosciences Announces IND Submission of MBX 4291, its Long-acting GLP1/GIP Receptor Co-agonist Prodrug for the Treatment of Obesity
June 16, 2025
·
6 min read
Press Releases
MBX Biosciences Appoints Andreas Moraitis, M.D., as Senior Vice President of Clinical Development
June 23, 2025
·
5 min read
Press Releases
MBX Biosciences to Participate in Citizens and RBC May Investor Conferences
April 23, 2025
·
1 min read
Press Releases
MBX Biosciences Reports First Quarter 2025 Financial Results and Recent Corporate Highlights
May 12, 2025
·
9 min read
Press Releases
MBX Biosciences Announces Additions to Leadership Team
March 5, 2025
·
6 min read
Press Releases
MBX Biosciences Completes Enrollment in Phase 2 Avail™ Trial of MBX 2109 (Canvuparatide) for Hypoparathyroidism
March 3, 2025
·
7 min read
Press Releases
MBX Biosciences Appoints Veteran Pharmaceutical Executive Steve Hoerter to Board of Directors
April 7, 2025
·
6 min read
Press Releases
MBX Biosciences to Participate in the 24th Annual Needham Virtual Healthcare Conference
March 27, 2025
·
1 min read
Press Releases
MBX Biosciences to Participate in March 2025 Investor Conferences
February 19, 2025
·
1 min read
1 of 70,787
Next
